| Identification | Back Directory | [Name]
Ginsenoside Rb3 | [CAS]
68406-26-8 | [Synonyms]
NH25835
Gypenoside IV
xylopyranosyl-
GINSENOSIDE RB3
GINSENOSIDE Rb3(SH)
Ginsenoside Rb3 ,98%
Ginsenoside Rb3
Gypenoside IV
Ginsenoside Rb3 (CAS#68403-26-8)
hydroxydammar-24-en-20-yl6-O-β-D-
β-D-Glucopyranoside, (3β,12β)-3-[(2-O-β-D-
Ginsenoside Rb3, 98%, from Panax ginseng C. A. Mey.
glucopyranosyl)oxy)-12-hydroxydammar-24-en-20-yl6-o-beta-d-xylopyranosyl-
(3-beta,12-beta)-3-((2-o-beta-d-glucopyranosyl-beta-d-alpha-d-glucopyranosid
(3β,12β)-3-[(2-O-β-D-Glucopyranosyl-β-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-20-yl 6-O-β-D-xylopyranosyl-β-D-glucopyranoside
β-D-Glucopyranoside, (3β,12β)-3-[(2-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-20-yl 6-O-β-D-xylopyranosyl-
[3β-[[2-O-(β-D-Glucopyranosyl)-β-D-glucopyranosyl]oxy]-12β-hydroxy-5α-dammar-24-en-20-yl]6-O-(β-D-xylopyranosyl)-β-D-glucopyranoside
b-D-Glucopyranoside, (3b,12b)-3-[(2-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-20-yl 6-O-b-D-xylopyranosyl-
(2S,3R,4S,5S,6R)-2-[[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(10R,12S,14R)-12-hydroxy-4,4,10,14-tetramethyl-17-[(E,2R)-6-methyl-2-[[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4 | [Molecular Formula]
C53H90O22 | [MDL Number]
MFCD00221756 | [MOL File]
68406-26-8.mol | [Molecular Weight]
1079.27 |
| Chemical Properties | Back Directory | [Melting point ]
193～195℃ | [Boiling point ]
1117.1±65.0 °C(Predicted) | [density ]
1.42±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO (Slightly), Methanol (Slightly), Pyridine (Slightly) | [form ]
neat | [pka]
12.85±0.70(Predicted) | [color ]
White | [Water Solubility ]
insoluble in water | [Stability:]
Hygroscopic | [CAS DataBase Reference]
68406-26-8 |
| Hazard Information | Back Directory | [Uses]
Ginsenoside Rb3 inhibits the upregulation of phospho-IκB-α and nuclear translocation of NF-κB subunit p65 induced by glucose deprivation then reperfusion. |
|
|